Selective targeting of NRF2-high pancreatic ductal adenocarcinoma with an NQO1-activatable prodrug. - Antonucci L; Watari K; Feng Y; Qi J; Zhu M; Wang T; Ng I; Vucic EA; Riahi I; Huang L; Hosseini M; Mose E; et al. (Proceedings of the National Academy of Sciences of the United States of America, 2026)